Search Result

Results for "

Preterm

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adrenergic Receptor (3) Endogenous Metabolite (1) Oxytocin Receptor (9) Prostaglandin Receptor (1) Toll-like Receptor (TLR) (1) Vasopressin Receptor (5)
By Research Areas:	Cancer (4) Endocrinology (12) Inflammation/Immunology (4) Metabolic Disease (1)

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B0452

Ritodrine hydrochloride 2 Publications Verification DU21220 hydrochloride	Adrenergic Receptor	Endocrinology
Ritodrine (DU21220) hydrochloride is a potent and orally active β-adrenergic agonist. Ritodrine hydrochloride decreases preterm delivery and uterine contraction. Ritodrine hydrochloride has the potential for the research of preterm labor .

HY-17572

Atosiban 4 Publications Verification RW22164; RWJ22164	Oxytocin Receptor Vasopressin Receptor	Endocrinology Cancer
Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .

HY-17572A

Atosiban acetate 4 Publications Verification RW22164 acetate; RWJ22164 acetate	Oxytocin Receptor Vasopressin Receptor	Endocrinology Cancer
Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .

HY-B0452A

Ritodrine DU21220	Adrenergic Receptor	Endocrinology
Ritodrine (DU21220) is a potent and orally active β-adrenergic agonist. Ritodrine decreases preterm delivery and uterine contraction. Ritodrine has the potential for the research of preterm labor .

HY-B0452R

Ritodrine hydrochloride (Standard)	Adrenergic Receptor	Endocrinology
Ritodrine (hydrochloride) (Standard) is the analytical standard of Ritodrine (hydrochloride). This product is intended for research and analytical applications. Ritodrine (DU21220) hydrochloride is a potent and orally active β-adrenergic agonist. Ritodrine hydrochloride decreases preterm delivery and uterine contraction. Ritodrine hydrochloride has the potential for the research of preterm labor .

HY-113111

11,12-DiHETrE	Endogenous Metabolite	Inflammation/Immunology
11,12-DiHETrE, an endogenous metabolite, is a Cytochrome P450 (P450) eicosanoid. 11,12-DiHETrE can be used for preterm labor research. 11,12-DiHETrE can be used as a single biomarker for differentiating NAFL (nonalcoholic fatty liver) from NASH (nonalcoholic steatohepatitis) .

HY-129333

L-364918	Oxytocin Receptor Vasopressin Receptor	Metabolic Disease
L-364918 is a potent and selective oxytocin and arginine vasopressin antagonist with K_i values of 30, 1300, 2400 nM for OT, AVP-V1, AVP-V2, respectively. L-364918 has the potential for the research of preterm labor and disturbances in water balance .

HY-17572R

Atosiban (Standard)	Oxytocin Receptor Vasopressin Receptor	Endocrinology Cancer
Atosiban (Standard) is the analytical standard of Atosiban. This product is intended for research and analytical applications. Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .

HY-17572AR

Atosiban acetate (Standard)	Oxytocin Receptor Vasopressin Receptor	Endocrinology Cancer
Atosiban (acetate) (Standard) is the analytical standard of Atosiban (acetate). This product is intended for research and analytical applications. Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .

HY-P3516

Barusiban FE-200440	Oxytocin Receptor	Endocrinology
Barusiban (FE-200440) is an oxytocin receptor (OT-R) antagonist (K_i=0.8 nM), inhibits OT-induced contraction. Barusiban can be used in preterm labor (PTL), in vitro fertilisation (IVF) and infertility research .

HY-15008

L-368,899	Oxytocin Receptor	Endocrinology
L-368,899 is an orally active and selective OT (oxytocin ) receptor antagonist, with IC₅₀s of 8.9 and 26 nM for uterus of rat and human, respectively. L-368,899 can cross the blood-brain barrier (BBB). L-368,899 inhibits oxytocin-stimulated uterine contractions in rats and can be used in study of preterm labor .

HY-13570B

Betamethasone acetate	Others	Inflammation/Immunology
Betamethasone acetate is a glucocorticoid corticosteroid. Betamethasone acetate induces fetal lung maturation in preterm sheep .

HY-13570BR

Betamethasone acetate (Standard)	Others	Inflammation/Immunology
Betamethasone acetate (Standard) is the analytical standard of Betamethasone acetate. This product is intended for research and analytical applications. Betamethasone acetate is a glucocorticoid corticosteroid. Betamethasone acetate induces fetal lung maturation in preterm sheep .

HY-120585

L-365209	Oxytocin Receptor	Endocrinology
L-365209 is a oxytocin antagonist and can be isolated from Streptomyces .

HY-P4160

PDC31 THG113.31; ILGHXDYK	Prostaglandin Receptor	Endocrinology
PDC31 (THG113.31; ILGHXDYK) is an allosteric and non-competitive inhibitor of FP Prostaglandin Receptor. PDC31 is the D-amino acid-based oligopeptide, is used for smooth muscle contractile agent. PDC31 decreases the strength and duration of uterine contractions in vivo, which can be used for research of preterm labor and primary dysmenorrhea (PD). PDC31 also enhances Ca ²⁺-dependent large-conductance K ⁺-channel in human myometrial cells .

HY-D1056A4

Lipopolysaccharides, from E. coli O128:B12 LPS, from Escherichia coli (O128:B12)	Toll-like Receptor (TLR)	Inflammation/Immunology
Lipopolysaccharides, from E. coli O128:B12 is commonly used to stimulate the inflammatory pathway in an infection/inflammation induced preterm animal model. Specific Lipopolysaccharides from E. coli serotypes induce activation of different inflammatory pathways in the neonatal rat brain. Compared with other Escherichia coli, Lipopolysaccharides (O111:B4, O55:B5, O127:B8), Lipopolysaccharides, from E. coli O128:B12 has lower induction efficiency of inflammation. Cub survival rate was 100% after the treatment .

HY-15018A

SSR126768A free base	Oxytocin Receptor	Endocrinology
SSR126768A free base is an orally active antagonist for oxytocin receptor, with K_i of 0.44 nM. SSR126768A free base is a tocolytic agent, that antagonizes the Oxytocin (HY-17571)-induced intracellular Ca ²⁺ increase and prostaglandin release in human uterine smooth muscle cells, inhibits thus the Oxytocin (HY-17571)-induced uterine contraction and delays parturition in pregnant rats in labor .

Cat. No.	Product Name	Type

HY-D1056A4

Lipopolysaccharides, from E. coli O128:B12 LPS, from Escherichia coli (O128:B12)	Carbohydrates
Lipopolysaccharides, from E. coli O128:B12 is commonly used to stimulate the inflammatory pathway in an infection/inflammation induced preterm animal model. Specific Lipopolysaccharides from E. coli serotypes induce activation of different inflammatory pathways in the neonatal rat brain. Compared with other Escherichia coli, Lipopolysaccharides (O111:B4, O55:B5, O127:B8), Lipopolysaccharides, from E. coli O128:B12 has lower induction efficiency of inflammation. Cub survival rate was 100% after the treatment .

Lipopolysaccharides, from E. coli O128:B12

LPS, from Escherichia coli (O128:B12)

Carbohydrates

Lipopolysaccharides, from E. coli O128:B12 is commonly used to stimulate the inflammatory pathway in an infection/inflammation induced preterm animal model. Specific Lipopolysaccharides from E. coli serotypes induce activation of different inflammatory pathways in the neonatal rat brain. Compared with other Escherichia coli, Lipopolysaccharides (O111:B4, O55:B5, O127:B8), Lipopolysaccharides, from E. coli O128:B12 has lower induction efficiency of inflammation. Cub survival rate was 100% after the treatment .

Cat. No.	Product Name	Target	Research Area